SHOCKING: 5 - You Need To See This

Trump administration advances plan for peptide drugs favored by RFK Jr.

Federal health officials are moving ahead with plans to broaden access to a class of unproven injectable drugs called peptides

The Independent UK · Oct 15

CVS Agrees to Pay $315 Million Over Claims Its Pharmacies Filled Unlawful Opioid Prescriptions, Including Risky Drug Combinations

CVS will pay $315 million to settle federal claims that its pharmacies filled unlawful opioid prescriptions. Here is what the government alleged and why it matters.

Medical Daily · Oct 15

Par Health Recalls 22 Lots of Hospital Blood Thinner Argatroban After Particles, Possibly Stainless Steel, Found in Vials

Par Health is recalling 22 lots of Argatroban Injection after particles, possibly including stainless steel, were detected. See lot numbers, NDCs, and steps for hospitals.

Medical Daily · Oct 15

Argenx Stops Phase 3 Vyvgart Trial in Sjögren's Disease After Monitors Find the Study Cannot Meet Its Goal

Argenx ended its Phase 3 UNITY trial of efgartigimod in Sjögren's disease after a futility review. No new safety signals were found.

Medical Daily · Oct 13

Hospital Pharmacies Must Stop Using Two Nationwide Lots of Brevital Anesthetic After Par Health Finds Cellulose in Vials

Par Health recalled Brevital lots 86930 and 88623 after cellulose was found in vials. Steps hospitals must take and what sedation patients can ask.

Medical Daily · Oct 13

638,000 Medicare Beneficiaries in 193 Counties Will Have No General Medicare Advantage Drug Plan for 2027

KFF finds 193 counties will have no general Medicare Advantage drug plan in 2027, up from 123. What it means for coverage before open enrollment.

Medical Daily · Oct 13

Jefferies lists 6 factors that will shape CRDMO winners; Divi’s Labs, Sai Life, Laurus, Anthem among stocks to watch

India's CRDMO sector is on the brink of expansion, backed by solid partnerships with major pharmaceutical players and comprehensive capabilities. Jefferies emphasizes the critical role of specialized manufacturing skills and a strong project pipeline for achieving success. With Divi's Laboratories and Sai Life Sciences excelling in these domains, there is…

The Economic Times · Oct 13

Jubilant Pharmova block deal: Quant Mutual Fund offloads Rs 190 crore stake amid Rs 800 crore fundraising plan; Abakkus buys 11 lakh shares

Quant Mutual Fund sold 20.81 lakh shares of Jubilant Pharmova worth Rs 190.47 crore in bulk deals, while Abakkus Four2Eight Opportunities Fund bought 11 lakh shares. The transactions came as the pharmaceutical company approved plans to raise up to Rs 800 crore through non-convertible debentures and seek broader debt issuance…

The Economic Times · Oct 12

Par Health Recalls Two Brevital Anesthetic Lots Over Cellulose Particles That Could Block Blood Vessels in the Lungs

Par Health recalled two Brevital anesthetic lots after cellulose particles were found. See the lot numbers and what surgery and ECT patients can ask about.

Medical Daily · Oct 12

Mail-Order Prescriptions From Canada Could Face Delays or Refusals When a Customs Rule's Grace Period Ends October 22

A CBP mail rule hits its Oct. 22 compliance date, and Canadian prescription shipments could face delays or refusals. What patients should check now.

Medical Daily · Oct 12